Get complete access to comprehensive company data for Nextgen In-vitro Diagnostics Private Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Nextgen In-vitro Diagnostics Private Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 4.05 cr
₹ 1.88 cr
24 Apr 2015
31 Mar 2024
Nextgen In-Vitro Diagnostics Private Limited is an Indian private limited company incorporated on 24 Apr 2015. The company's registered office is situated in Delhi, India.
The current status of Nextgen In-Vitro Diagnostics Private Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2024 (FY 2023-2024).
Nextgen In-Vitro Diagnostics Private Limited is a company limited by shares with an authorized capital of ₹4.05 cr and a paid-up capital of ₹1.88 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Nextgen In-Vitro Diagnostics Private Limited has 5 directors. The directors of the company include Devashish Ohri, Sushil Mehta, Ashok Kumar Jain, Pankaj Krishna.
The registered office of Nextgen In-Vitro Diagnostics Private Limited is located at C-1/59 Safdarjung Development Area New Delhi Delhi 110016 India in Delhi, India.
- CIN/LLPIN/FCRN: U33110DL2015PTC279481
- Legal Name: Nextgen In-vitro Diagnostics Private Limited
- ROC Code: Roc Delhi
- Company No.: 279481
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Private
- Listing Status: Unlisted
- Industry: Healthcare
- Date of AGM: 30 Sep 2024
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Nextgen In-Vitro Diagnostics Private Limited |
|---|
Frequently Asked Questions
- ashok kumar jain
- devashish ohri
- pankaj krishna
- sushil mehta
- varun chopra